Does cannabis interact with Metoprolol?

**Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare provider before combining cannabis with any medications.** Cannabis can potentially interact with metoprolol, a beta-blocker commonly prescribed for high blood pressure and heart conditions. Both substances affect the cardiovascular system, which raises important safety considerations. Metoprolol works by blocking beta-adrenergic receptors, reducing heart rate and blood pressure. Cannabis, particularly THC, can cause variable cardiovascular effects including increased heart rate (tachycardia), changes in blood pressure, and altered cardiac output. These opposing mechanisms may create unpredictable interactions. Key interaction concerns include: **Cardiovascular Effects**: THC typically increases heart rate by 20-30 beats per minute, while metoprolol is designed to slow it down. This contradiction may reduce metoprolol's effectiveness or cause cardiovascular stress. **Blood Pressure Variations**: Cannabis can cause both hypotension and hypertension depending on dose, strain, and individual response. When combined with metoprolol's blood pressure-lowering effects, this may lead to dangerous drops in blood pressure. **Metabolic Interactions**: Both substances are metabolized by liver enzymes (CYP450 system). Cannabis compounds may theoretically affect how quickly metoprolol is processed, potentially altering its effectiveness or duration. **Clinical Evidence**: While comprehensive studies on this specific interaction are limited, case reports suggest cannabis use may interfere with beta-blocker therapy effectiveness. A 2019 study in the Journal of Clinical Medicine noted that cannabis use in cardiac patients required careful monitoring. **Safety Recommendations**: Patients taking metoprolol should inform their cardiologist about cannabis use. Medical supervision is essential, as dosage adjustments may be necessary. Regular blood pressure and heart rate monitoring is recommended when using both substances. The interaction risk appears moderate to high, particularly for patients with existing cardiovascular conditions. Individual responses vary significantly based on cannabis potency, consumption method, frequency of use, and overall health status.